Senesys.Bio

Senesys.Bio is a University of Cambridge spinout developing nanomedicine-based drug delivery technology for age-related diseases.

Its NanoJAGGs platform uses nanoscale structures designed to accumulate in senescent cells and deliver therapeutic compounds within them. The company aims to improve the selectivity of senolytic treatments while limiting effects on healthy tissue.

Initial development focuses on idiopathic pulmonary fibrosis, with potential applications in other conditions associated with cellular senescence.